| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 2-Yr Return |
|---|---|---|---|---|---|
|
GB:0QBO
Coloplast A/S
|
Sep 10, 2025 | HOLD |
Buy
+86.3% avg upside
16 analysts
|
$670.00
77.51% Upside
|
· |
|
QGEN
Qiagen
|
Sep 10, 2025 | HOLD |
Buy
+14.0% avg upside
23 analysts
|
$47.08
27.49% Upside
|
-28.8% |
|
FR:BIM
bioMerieux
|
Sep 08, 2025 | BUY |
Buy
+51.8% avg upside
12 analysts
|
$140.00
102.85% Upside
|
· |
|
CH:ALC
Alcon
|
Sep 08, 2025 | BUY |
Buy
+34.6% avg upside
35 analysts
|
$77.00
45.62% Upside
|
· |
|
CH:SOON
Sonova Holding AG
|
Sep 04, 2025 | HOLD |
Sell
+14.3% avg upside
17 analysts
|
$255.00
32.02% Upside
|
· |
|
GB:0K9P
GN Store Nord
|
Sep 04, 2025 | HOLD |
Hold
+165.7% avg upside
13 analysts
|
$130.00
43.53% Upside
|
· |
|
CH:TECN
Tecan Group AG
|
Aug 19, 2025 | HOLD |
Buy
+110.2% avg upside
8 analysts
|
$180.00
18.74% Upside
|
· |
|
WILLF
Demant
|
Aug 18, 2025 | BUY |
Buy
+9.9% avg upside
19 analysts
|
$48.34
36.39% Upside
|
-6.5% |
|
CH:STMN
Straumann Holding AG
|
Aug 13, 2025 | BUY |
Buy
+20.6% avg upside
13 analysts
|
$150.00
43.33% Upside
|
· |
|
CH:GALE
Galenica AG
|
Aug 08, 2025 | HOLD |
Hold
-0.2% avg upside
3 analysts
|
$89.00
5.64% Upside
|
· |
|
IT:DIA
DiaSorin S.p.A.
|
Aug 01, 2025 | HOLD |
Hold
+65.5% avg upside
10 analysts
|
$96.00
47.64% Upside
|
· |
|
DE:SHL
Siemens Healthineers AG
|
Sep 29, 2021 | BUY |
Buy
+51.7% avg upside
22 analysts
|
$57.50
67.94% Upside
|
· |
|
DE:ILM1
Medios AG
|
Sep 29, 2021 | BUY |
Strong Buy
+220.8% avg upside
5 analysts
|
$46.00
261.03% Upside
|
· |
|
NYXH
Nyxoah
|
Sep 29, 2021 | BUY |
Strong Buy
+849.7% avg upside
12 analysts
|
$32.11
1907.19% Upside
|
-75.7% |
|
FR:EMEIS
Orpea SA
|
Sep 29, 2021 | BUY |
Buy
+538.0% avg upside
4 analysts
|
$155.00
976.36% Upside
|
· |
|
IT:AMP
Amplifon S.p.A.
|
Sep 29, 2021 | HOLD |
Hold
+154.0% avg upside
13 analysts
|
$43.00
320.81% Upside
|
· |
|
DE:AFX
Carl Zeiss Meditec
|
Sep 29, 2021 | HOLD |
Hold
+91.0% avg upside
13 analysts
|
$180.00
621.78% Upside
|
· |
|
DE:COP
CompuGroup Medical
|
Sep 29, 2021 | HOLD |
Buy
+63.5% avg upside
11 analysts
|
$65.00
136.34% Upside
|
· |
|
GB:0HNZ
Fagron SA
|
Sep 29, 2021 | HOLD |
Buy
-8.1% avg upside
5 analysts
|
$20.75
13.70% Downside
|
· |
|
DE:FIE
Fielmann
|
Sep 29, 2021 | BUY |
Strong Buy
+38.8% avg upside
9 analysts
|
$78.00
79.58% Upside
|
· |
|
DE:FRE
Fresenius SE & Co. KGaA
|
Sep 29, 2021 | BUY |
Buy
+29.7% avg upside
19 analysts
|
$53.00
33.79% Upside
|
· |
|
DE:GXI
Gerresheimer
|
Sep 29, 2021 | SELL |
Buy
+143.2% avg upside
14 analysts
|
$88.00
243.72% Upside
|
· |
|
NL:PHIA
Koninklijke Philips N.V.
|
Sep 29, 2021 | HOLD |
Buy
+31.2% avg upside
20 analysts
|
$45.00
91.40% Upside
|
· |
|
FR:CLARI
Clariane
|
Sep 29, 2021 | BUY |
Strong Buy
+482.3% avg upside
4 analysts
|
$42.00
930.43% Upside
|
· |
|
DE:VQT
va Q tec
|
Sep 29, 2021 | BUY |
Strong Buy
+21.1% avg upside
5 analysts
|
$32.00
23.97% Upside
|
· |
|
PHG
Koninklijke Philips
|
Jul 16, 2021 | HOLD |
Strong Buy
+30.8% avg upside
13 analysts
|
$51.61
92.76% Upside
|
-48.9% |
|
GRFS
Grifols SA
|
Jul 16, 2021 | HOLD |
Hold
+240.8% avg upside
12 analysts
|
$27.76
275.05% Upside
|
-39.7% |
|
DE:RHK
RHON-KLINIKUM AG
|
Mar 19, 2021 | HOLD |
Hold
+42.9% avg upside
3 analysts
|
$18.00
42.91% Upside
|
· |
|
DE:SBS
STRATEC Biomedical
|
Dec 09, 2020 | BUY |
Strong Buy
+227.9% avg upside
5 analysts
|
$129.00
609.62% Upside
|
· |
|
SE:GETI.B
Getinge
|
Aug 28, 2020 | BUY |
Hold
+14.3% avg upside
7 analysts
|
$255.00
31.56% Upside
|
· |
|
FR:ALMKT
MAUNA KEA TECHNOLOGIES
|
Oct 24, 2019 | SELL |
Strong Sell
+1039.3% avg upside
2 analysts
|
$1.50
876.55% Upside
|
· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.